Cite
HARVARD Citation
Rosas, I. et al. (2022). Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA). EClinicalMedicine. p. . [Online].